Yuyu enjoys robust sales of Yuclid

Yuyu Pharm has recently had its big smiles over the better-than-expected revenues of Yuclid tablets, of a combination of ticlopidine and ginkgo biloba extract.

The company said Yuclid achieved 2.6 billion won in sales last year, thanks much to market recognition of the product’s excellent efficacy and less side effects.

“Local doctors have expressed keen attention on antithrombic effects ...